JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
1 hedge funds and large institutions have $918K invested in Jounce Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 83 closing their positions.
Holders
1
Holders Change
-83
Holders Change %
-98.81%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
83
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AB
76
Amalgamated Bank
New York
| – | -$7K | -3,951 | Closed |
|
77
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$6.67K | -3,606 | Closed |
|
78
Legal & General Group
London,
United Kingdom
| – | -$6.52K | -3,523 | Closed |
|
79
Simplex Trading
Chicago,
Illinois
| – | -$6K | -3,373 | Closed |
|
|
AIP
80
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$4.78K | -2,585 | Closed |
|
81
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -2,358 | Closed |
|
82
Osaic Holdings
Scottsdale,
Arizona
| – | -$4.35K | -2,350 | Closed |
|
|
CB
83
Community Bank
Dewitt,
New York
| – | -$1.84K | -1,000 | Closed |
|
84
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$1K | -562 | Closed |
|